François Aguet,Kristin G. Ardlie,Beryl B. Cummings,Ellen T. Gelfand,Gad Getz,Kane Hadley,Robert E. Handsaker,Katherine H. Huang,Seva Kashin,Konrad J. Karczewski,Monkol Lek,Xiao Li,Daniel G. MacArthur,Jared L. Nedzel,Duyen T. Nguyen,Michael S. Noble,Ayellet V. Segrè,Casandra A. Trowbridge,Taru Tukiainen,Nathan S. Abell,Brunilda Balliu,Ruth Barshir,Omer Basha,Alexis Battle,Gireesh K. Bogu,Andrew Brown,Christopher D. Brown,Stephane E. Castel,Lin S. Chen,Colby Chiang,Donald F. Conrad,Nancy J. Cox,Farhan N. Damani,Joe R. Davis,Olivier Delaneau,Emmanouil T. Dermitzakis,Barbara E. Engelhardt,Eleazar Eskin,Pedro G. Ferreira,Laure Frésard,Eric R. Gamazon,Diego Garrido-Martín,Ariel D.H. Gewirtz,Genna Gliner,Michael J. Gloudemans,Roderic Guigo,Ira M. Hall,Buhm Han,Yuan He,Farhad Hormozdiari,Cedric Howald,Hae Kyung Im,Brian Jo,Eun Yong Kang,Yungil Kim,Sarah Kim-Hellmuth,Tuuli Lappalainen,Gen Li,Xin Li,Boxiang Liu,Serghei Mangul,Mark I. McCarthy,Ian C. McDowell,Pejman Mohammadi,Jean Monlong,Stephen B. Montgomery,Manuel Muñoz-Aguirre,Anne W. Ndungu,Dan L. Nicolae,Andrew B. Nobel,Meritxell Oliva,Halit Ongen,John J. Palowitch,Nikolaos Panousis,Panagiotis Papasaikas,YoSon Park,Princy Parsana,Anthony J. Payne,Christine B. Peterson,Jie Quan,Ferran Reverter,Chiara Sabatti,Ashis Saha,Michael Sammeth,Alexandra J. Scott,Andrey A. Shabalin,Reza Sodaei,Matthew Stephens,Barbara E. Stranger,Benjamin J. Strober,Jae Hoon Sul,Emily K. Tsang,Sarah Urbut,Martijn van de Bunt,Gao Wang,Xiaoquan Wen,Fred A. Wright,Hualin S. Xi,Esti Yeger-Lotem,Zachary Zappala,Judith B. Zaugg,Yi-Hui Zhou,Joshua M. Akey,Daniel Bates,Joanne Chan,Lin S. Chen,Melina Claussnitzer,Kathryn Demanelis,Morgan Diegel,Jennifer A. Doherty,Andrew P. Feinberg,Marian S. Fernando,Jessica Halow,Kasper D. Hansen,Eric Haugen,Peter F. Hickey,Lei Hou,Farzana Jasmine,Ruiqi Jian,Lihua Jiang,Audra Johnson,Rajinder Kaul,Manolis Kellis,Muhammad G. Kibriya,Kristen Lee,Jin Billy Li,Qin Li,Xiao Li,Jessica Lin,Shin Lin,Sandra Linder,Caroline Linke,Yaping Liu,Matthew T. Maurano,Benoit Molinie,Stephen B. Montgomery,Jemma Nelson,Fidencio J. Neri,Meritxell Oliva,Yongjin Park,Brandon L. Pierce,Nicola J. Rinaldi,Lindsay F. Rizzardi,Richard Sandstrom,Andrew Skol,Kevin S. Smith,Michael P. Snyder,John Stamatoyannopoulos,Barbara E. Stranger,Hua Tang,Emily K. Tsang,Li Wang,Meng Wang,Nicholas Van Wittenberghe,Fan Wu,Rui Zhang,Concepcion R. Nierras,Philip A. Branton,Latarsha J. Carithers,Ping Guan,Helen M. Moore,Abhi Rao,Jimmie B. Vaught,Sarah E. Gould,Nicole C. Lockart,Casey Martin,Jeffery P. Struewing,Simona Volpi,Anjene M. Addington,Susan E. Koester,A. Roger Little,Lori E. Brigham,Richard Hasz,Marcus Hunter,Christopher Johns,Mark Johnson,Gene Kopen,William F. Leinweber,John T. Lonsdale,Alisa McDonald,Bernadette Mestichelli,Kevin Myer,Brian Roe,Michael Salvatore,Saboor Shad,Jeffrey A. Thomas,Gary Walters,Michael Washington,Joseph Wheeler,Jason Bridge,Barbara A. Foster,Bryan M. Gillard,Ellen Karasik,Rachna Kumar,Mark Miklos,Michael T. Moser,Scott D. Jewell,Robert G. Montroy,Daniel C. Rohrer,Dana R. Valley,David A. Davis,Deborah C. Mash,Anita H. Undale,Anna M. Smith,David E. Tabor,Nancy V. Roche,Jeffrey A. McLean,Negin Vatanian,Karna L. Robinson,Leslie Sobin,Mary E. Barcus,Kimberly M. Valentino,Liqun Qi,Steven Hunter,Pushpa Hariharan,Shilpi Singh,Ki Sung Um,Takunda Matose,Maria M. Tomaszewski,Laura K. Barker,Maghboeba Mosavel,Laura A. Siminoff,Heather M. Traino,Paul Flicek,Thomas Juettemann,Magali Ruffier,Dan Sheppard,Kieron Taylor,Stephen J. Trevanion,Daniel R. Zerbino,Brian Craft,Mary Goldman,Maximilian Haeussler,W. James Kent,Christopher M. Lee,Benedict Paten,Kate R. Rosenbloom,John Vivian,Jingchun Zhu,,Gaelen T. Hess,Amy Li,Andrea Ganna,Michael C. Bassik,Jason D. Merker

Abstract:Abstract Rare genetic variants are abundant in humans and are expected to contribute to individual disease risk 1,2,3,4 . While genetic association studies have successfully identified common genetic variants associated with susceptibility, these studies are not practical for identifying rare variants 1,5 . Efforts to distinguish pathogenic variants from benign rare variants have leveraged the genetic code to identify deleterious protein-coding alleles 1,6,7 , but no analogous code exists for non-coding variants. Therefore, ascertaining which rare variants have phenotypic effects remains a major challenge. Rare non-coding variants have been associated with extreme gene expression in studies using single tissues 8,9,10,11 , but their effects across tissues are unknown. Here we identify gene expression outliers, or individuals showing extreme expression levels for a particular gene, across 44 human tissues by using combined analyses of whole genomes and multi-tissue RNA-sequencing data from the Genotype-Tissue Expression (GTEx) project v6p release 12 . We find that 58% of underexpression and 28% of overexpression outliers have nearby conserved rare variants compared to 8% of non-outliers. Additionally, we developed RIVER (RNA-informed variant effect on regulation), a Bayesian statistical model that incorporates expression data to predict a regulatory effect for rare variants with higher accuracy than models using genomic annotations alone. Overall, we demonstrate that rare variants contribute to large gene expression changes across tissues and provide an integrative method for interpretation of rare variants in individual genomes.

Misexpression of inactive genes in whole blood is associated with nearby rare structural variants

Whole genome and RNA sequencing of 1,220 cancers reveals hundreds of genes deregulated by rearrangement of cis-regulatory elements

Aberrant Gene Expression in Humans

The impact of rare variation on gene expression across tissues

Variant-to-function dissection of rare non-coding GWAS loci with high impact on blood traits

Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Transcriptomic signatures across human tissues identify functional rare genetic variation

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

Assessing the diagnostic impact of blood transcriptome profiling in a pediatric cohort previously assessed by genome sequencing

Patterns of extreme outlier RNA expression in population data reveal sporadic over-activation of genes with co-regulated modules in subsets of individuals

Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes

RNA variant assessment using transactivation and transdifferentiation

Genetic variants associated with cell-type-specific intra-individual gene expression variability reveal new mechanisms of genome regulation

Long-read DNA and cDNA sequencing identify cancer-predisposing deep intronic variation in tumor-suppressor genes

Disrupting upstream translation in mRNAs is associated with human disease

Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression

Whole genome sequencing identifies structural variants contributing to hematologic traits in the NHLBI TOPMed program

Mapping and characterization of structural variation in 17,795 deeply sequenced human genomes

On the cross-population generalizability of gene expression prediction models

Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease